Vipul Jairath Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

1/2024	Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn's Disease: A Systematic Review and Network Meta-Analysis.
12/2023	Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn's Disease: A Multicenter Study.
11/2023	Pharmacological therapies for the management of fistulising Crohn's disease: A systematic review and meta-analysis.
9/2023	Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis.
1/2023	Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
1/2023	Comparative Speed of Early Symptomatic Remission With Advanced Therapies for Moderate-to-Severe Ulcerative Colitis: A Systematic Review and Network Meta-Analysis.
10/2022	Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
1/2022	Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery: Meta-Analysis.
1/2022	Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
2/2021	Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vipul Jairath Research Topics

Disease

87	Crohn Disease (Crohn's Disease) 05/2024 - 08/2016
84	Ulcerative Colitis 06/2024 - 11/2016
38	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2024 - 01/2017
36	Hemorrhage 06/2024 - 09/2011
17	Inflammation (Inflammations) 05/2024 - 01/2017
16	Infections 01/2024 - 04/2017
9	Necrosis 03/2023 - 01/2018
7	Fibrosis (Cirrhosis) 05/2024 - 01/2017
7	Fistula 12/2023 - 01/2018
7	Pouchitis 03/2023 - 08/2017
6	Neoplasms (Cancer) 01/2024 - 04/2017
6	Pathologic Constriction (Stenosis) 10/2023 - 02/2019
6	Ulcer 10/2023 - 01/2019
4	Colitis 06/2024 - 02/2018
4	Wounds and Injuries (Trauma) 10/2021 - 11/2014
3	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2023 - 02/2019
3	Abscess 01/2022 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 05/2017
2	Proctitis 10/2023 - 01/2023
2	Chronic Disease (Chronic Diseases) 01/2023 - 01/2017
2	Microscopic Colitis 01/2023 - 01/2022
2	Peptic Ulcer (Peptic Ulcers) 01/2022 - 01/2021
2	Common Variable Immunodeficiency 01/2022 - 01/2020
2	Enterocolitis 01/2022 - 01/2022
2	Body Weight (Weight, Body) 01/2021 - 01/2020
2	Eosinophilic Esophagitis 01/2021 - 09/2019
2	Intraabdominal Infections 11/2020 - 10/2020
2	Shock 01/2019 - 05/2013
1	Angiodysplasia 02/2024
1	Malacoplakia 01/2024
1	Metaplasia 12/2023

Drug/Important Bio-Agent (IBA)

31	vedolizumabIBA 01/2024 - 04/2017
21	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024 - 01/2017
20	Infliximab (Remicade)FDA Link 06/2024 - 12/2018
18	Ustekinumab (CNTO 1275)FDA Link 01/2024 - 12/2018
15	tofacitinibIBA 06/2024 - 01/2020
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 12/2018
12	Leukocyte L1 Antigen Complex (Calgranulin)IBA 03/2024 - 07/2017
11	Adalimumab (Humira)FDA Link 01/2024 - 11/2019
9	Tumor Necrosis Factor InhibitorsIBA 01/2024 - 12/2018
9	Phenobarbital (Luminal)FDA Link 10/2023 - 01/2018
8	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2017
8	C-Reactive ProteinIBA 02/2024 - 07/2017
8	Janus Kinase InhibitorsIBA 11/2023 - 01/2019
8	IntegrinsIBA 03/2023 - 01/2019
7	Monoclonal AntibodiesIBA 01/2023 - 04/2017
6	Interleukin-12 (IL 12)IBA 01/2024 - 02/2019
6	mirikizumabIBA 11/2023 - 01/2022
6	Immunosuppressive Agents (Immunosuppressants)IBA 05/2023 - 08/2019
5	InterleukinsIBA 01/2024 - 02/2019
5	Interleukin-23 (Interleukin 23)IBA 07/2023 - 08/2018
5	ozanimodIBA 03/2023 - 01/2019
5	AntibodiesIBA 11/2021 - 01/2017
4	Immunologic Factors (Immunomodulators)IBA 04/2024 - 10/2020
4	AnticoagulantsIBA 12/2023 - 07/2014
4	golimumab FDA Link 05/2023 - 01/2020
4	Budesonide (Pulmicort)FDA LinkGeneric 01/2023 - 07/2017
4	Mesalamine (Mesalazine)FDA LinkGeneric 01/2022 - 01/2018
4	CytokinesIBA 01/2020 - 02/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 02/2019
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
3	Tranexamic Acid (AMCA)FDA Link 10/2021 - 11/2014
3	Janus KinasesIBA 01/2020 - 01/2019
2	Investigational DrugsIBA 03/2024 - 08/2018
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2024 - 11/2023
2	Azathioprine (Imuran)FDA LinkGeneric 01/2024 - 12/2021
2	Methotrexate (Mexate)FDA LinkGeneric 09/2023 - 01/2020
2	risankizumabIBA 07/2023 - 12/2021
2	Ciprofloxacin (Cipro)FDA LinkGeneric 03/2023 - 01/2023
2	GLPG0634IBA 03/2023 - 01/2023
2	AntigensIBA 01/2023 - 11/2016
2	Phosphotransferases (Kinase)IBA 01/2022 - 02/2019
2	SteroidsIBA 01/2022 - 10/2019
2	EnzymesIBA 01/2022 - 12/2018
2	AlbuminsIBA 01/2022 - 01/2020
2	Biosimilar PharmaceuticalsIBA 03/2020 - 01/2020
2	Hemostatics (Antihemorrhagics)IBA 12/2019 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 12/2019 - 01/2018
2	Immunoglobulin G (IgG)IBA 11/2019 - 12/2018
2	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 01/2018
1	upadacitinibIBA 02/2024
1	Thalidomide (Thalomid)FDA Link 02/2024
1	etrasimodIBA 01/2024
1	etrolizumabIBA 01/2024
1	MucinsIBA 12/2023

Therapy/Procedure

86	Therapeutics 06/2024 - 08/2016
17	Biological Therapy 01/2024 - 01/2017
9	Blood Transfusion (Blood Transfusions) 12/2019 - 09/2011
6	Erythrocyte Transfusion 12/2023 - 09/2011
5	Restorative Proctocolectomy 01/2024 - 01/2018
5	Colectomy 01/2024 - 05/2017
4	Drug Therapy (Chemotherapy) 12/2022 - 01/2017
3	Aftercare (After-Treatment) 01/2024 - 10/2019
3	Remission Induction 01/2021 - 10/2018
2	Ileostomy 01/2023 - 12/2018
2	Liver Transplantation 12/2022 - 12/2020
2	Immunotherapy 12/2022 - 01/2022
2	Length of Stay 01/2022 - 01/2018
2	Time-to-Treatment 07/2019 - 11/2014
1	Endoscopes 12/2023